1.
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
by Leslie, R. David
Diabetologia, 2015, Vol.59 (1), p.13-20
2.
Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
by Peters, Anne L
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (11), p.3922-3937
3.
Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement
by Golden, Sherita Hill
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (9), p.E1579-E1639
4.
Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis
by Tricco, Andrea C, Dr
The Lancet (British edition), 2012, Vol.379 (9833), p.2252-2261
5.
A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetes
by Egan, AM
Diabetologia, 2017, Vol.60 (7), p.1190-1196
6.
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
by Cummings, David E
Diabetologia, 2016, Vol.59 (5), p.945-953
7.
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
by Rezania, Alireza
Nature biotechnology, 2014, Vol.32 (11), p.1121-1133
8.
Diabetes in pregnancy: a new decade of challenges ahead
by Schaefer-Graf, Ute
Diabetologia, 2018, Vol.61 (5), p.1012-1021
9.
Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
by Madsbad, Sten
Journal of diabetes and its complications, 2016, Vol.30 (2), p.374-385
10.
Diabetes Insipidus – Diagnosis and Management
by Di Iorgi, Natascia
Hormone research in paediatrics, 2012, Vol.77 (2), p.69-84
11.
12.
13.
Type 1 diabetes
by Atkinson, Mark A, Prof
The Lancet (British edition), 2014, Vol.383 (9911), p.69-82
14.
Care of diabetes in children and adolescents: controversies, changes, and consensus
by Cameron, Fergus J, Prof
The Lancet (British edition), 2015, Vol.385 (9982), p.2096-2106
15.
Clinical and socio-demographic determinants of self-care behaviours in patients with heart failure and diabetes mellitus: A multicentre cross-sectional study
by Ausili, Davide
International journal of nursing studies, 2016, Vol.63, p.18-27
16.
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
by UK Hypoglycaemia Study Group
Diabetologia, 2007, Vol.50 (6), p.1140-1147
17.
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
by Vallon, Volker
Annual review of medicine, 2015, Vol.66 (1), p.255-270
18.
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study
by McGurnaghan, Stuart J
Diabetologia, 2019, Vol.62 (4), p.621-632
19.
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities
by Brunkwall, Louise
Diabetologia, 2017, Vol.60 (6), p.943-951
20.
